87 results on '"Certal, V"'
Search Results
2. Portable power supply options for positive airway pressure devices
- Author
-
Riaz, M, Certal, V, and Camacho, M
- Published
- 2015
3. Sustained Therapeutic Benefits for at Least 3 Years in the THN3 Randomized, Controlled Trial of Targeted Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea
- Author
-
Schwartz, A.R., primary, Jacobowitz, O., additional, Mickelson, S.A., additional, Miller, M.B., additional, Oliven, A., additional, Certal, V., additional, Hopp, M.L., additional, Winslow, D.H., additional, Huntley, T.C., additional, Nachlas, N.E., additional, Eisele, D.W., additional, Gillespie, M.B., additional, Weeks, B.H., additional, Lovett, E.G., additional, Shen, J., additional, Malhotra, A., additional, and Maurer, J.T., additional
- Published
- 2023
- Full Text
- View/download PDF
4. Tissue-Sparing Uvulopalatopharyngoplasty for OSA: Conservative, Compassionate and Possibly just as Effective
- Author
-
Camacho, M., Certal, V., Modi, R., and Capasso, R.
- Published
- 2019
- Full Text
- View/download PDF
5. Three-year outcomes of Targeted Hypoglossal Nerve Stimulation randomized controlled trial (THN3) for Obstructive Sleep Apnea
- Author
-
Jacobowitz, O., Maurer, J., Mickelson, S., Miller, M., Oliven, A., Certal, V., Hopp, M., Winslow, D., Huntley, T., Nachlas, N., Eisele, D., Gillespie, M.B., Weeks, B., Lovett, E., Malhotra, A., and Schwartz, A.
- Published
- 2024
- Full Text
- View/download PDF
6. Dexmedetomidine versus propofol during drug-induced sleep endoscopy and sedation: a systematic review
- Author
-
Chang ET, Certal V, Song SA, Zaghi S, Carrasco-Llatas M, Torre C, Capasso R, and Camacho M
- Abstract
Background The purpose of the present study is to review the international literature, using a systematic review, for studies comparing propofol and dexmedetomidine for drug-induced sleep endoscopy (DISE) or sedation in which there is a description of the effect of the agents on the upper airway and associated variables (e.g., vital signs, sedation scores). Methods This is a systematic review through October 4, 2016. PubMed/MEDLINE and four additional databases were accessed for this study. Results Two hundred twenty studies were screened. 79 were downloaded, and 10 met criteria. The majority of the studies identified dexmedetomidine as the preferred pharmacologic agent for DISE due to an overall safer and more stable profile based upon hemodynamic stability. However, propofol provided greater airway obstruction with oxygen desaturations. With either agent, the degree of obstruction in the upper airway lacks some degree of validity as to whether the obstructions accurately represent natural sleep or are simply a drug induced effect. Conclusion Dexmedetomidine and propofol have their advantages and disadvantages during DISE. Generally, dexmedetomidine was preferred and seemed to provide a more stable profile based upon cardiopulmonary status. However, propofol has a quicker onset, has a shorter half-life, and can demonstrate larger degrees of obstruction, which might more accurately reflect what happens during REM sleep. Additional research is recommended.
- Published
- 2017
7. A Major Breakthrough in the Use of Alkoxycarbene Complexes of Chromium and Tungsten for the Synthesis of Elaborate Organic Compounds: Dihydropyridine Induced Reductions and Cascade Insertion Reactions
- Author
-
Rudler, H., Parlier, A., Durand-Réville, T., Martin-Vaca, B., Audouin, M., Garrier, E., Certal, V., and Vaissermann, J.
- Published
- 2000
- Full Text
- View/download PDF
8. Supraglottoplasty for laryngomalacia with obstructive sleep apnea: A systematic review and meta-analysis
- Author
-
Camacho, M, Dunn, B, Torre, C, Sasaki, J, Gonzales, R, Liu, SC, Chan, DK, Certal, V, and Cable, BB
- Subjects
Apneia Obstrutiva do Sono ,Sleep Apnea, Obstructive ,Laringomalácia ,Laryngomalacia - Abstract
OBJECTIVES/HYPOTHESIS: To determine if apnea-hypopnea index (AHI) and lowest oxygen saturation (LSAT) improve following isolated supraglottoplasty for laryngomalacia with obstructive sleep apnea (OSA) in children. STUDY DESIGN: Systematic review and meta-analysis. METHODS: Nine databases, including PubMed/MEDLINE, were searched through September 30, 2015. RESULTS: A total of 517 studies were screened; 57 were reviewed; and 13 met criteria. One hundred thirty-eight patients were included (age range: 1 month-12.6 years). Sixty-four patients had sleep exclusive laryngomalacia, and in these patients: 1) AHI decreased from a mean (M) ± standard deviation (SD) of 14.0 ± 16.5 (95% confidence interval [CI] 10.0, 18.0) to 3.3 ± 4.0 (95% CI 2.4, 4.4) events/hour (relative reduction: 76.4% [95% CI 53.6, 106.4]); 2) LSAT improved from a M ± SD of 84.8 ± 8.4% (95% CI 82.8, 86.8) to 87.6 ± 4.4% (95% CI 86.6, 88.8); 3) standardized mean differences (SMD) demonstrated a small effect for LSAT and a large effect for AHI; and 4) cure (AHI < 1 event/hour) was 10.5% (19 patients with individual data). Seventy-four patients had congenital laryngomalacia, and in these patients: 1) AHI decreased from a M ± SD of 20.4 ± 23.9 (95% CI 12.8, 28.0) to 4.0 ± 4.5 (95% CI 2.6, 5.4) events/hour (relative reduction: 80.4% [95% CI 46.6, 107.4]); 2) LSAT improved from a M ± SD of 74.5 ± 11.9% (95% CI 70.9, 78.1) to 88.4 ± 6.6% (95% CI 86.4, 90.4); 3) SMD demonstrated a large effect for both AHI and LSAT; and 4) cure was 26.5% (38 patients with individual data). CONCLUSION: Supraglottoplasty has improved AHI and LSAT in children with OSA and either sleep exclusive laryngomalacia or congenital laryngomalacia; however, the majority of them are not cured.
- Published
- 2016
9. 0578 PREDICTORS OF SUCCESS FOR OSA TARGETED HYPOGLOSSAL NEUROSTIMULATION
- Author
-
Jacobowitz, O, primary, Bachar, G, additional, Certal, V, additional, Hohenhorst, W, additional, and Thuler, E, additional
- Published
- 2017
- Full Text
- View/download PDF
10. Adenoidectomy can improve obstructive sleep apnoea in young children: systematic review and meta-analysis
- Author
-
Reckley, L K, primary, Song, S A, additional, Chang, E T, additional, Cable, B B, additional, Certal, V, additional, and Camacho, M, additional
- Published
- 2016
- Full Text
- View/download PDF
11. BACKGROUND: Asthma and Allergic Rhinitis (AR) are two chronic inflammatory diseases that are often concomitant. The Control of Allergic Rhinitis and Asthma Test (CARAT) was developed to evaluate the control of these diseases from the patients' perspective. Its performance in asthma patients without AR has not been previously studied. AIM: To test the hypothesis that CARAT can be used to assess asthma control in patients with asthma and without AR. METHODS: A cross-sectional study was conducted in 3 primary healthcare centres in Northern Portugal. Adult patients identified in the Electronic Patient Record with a diagnosis of asthma were invited to participate. CARAT was used to assess asthma control and Asthma Control Test (ACT) as a comparator. The associations between asthma patients without AR (AsAR) and with AR (AwAR) were analyzed with Spearman correlation. Additionally, Receiver Operating Characteristic (ROC) curve analysis, summarized by Area Under the Curve (AUC), was used to assess performance of CARAT for screening asthma that was not well-controlled. RESULTS: A total of 103 asthma patients completed the study, 64 (62%) had AwAR and in 87 (85%) asthma was not well-controlled. We observed a strong correlation between CARAT and ACT scores (r=0.734) in all asthma patients and in both groups: AsAR (r=0.737) and AwAR (r=0.843). ROC curve demonstrated CARAT as having a good discriminative power for both AsAR and AwAR groups (AUC=0.894 and 0.946, respectively). CONCLUSION: These initial results suggest that CARAT has a good discriminative performance, similar to other asthma control assessment tools, for asthma patients with and without AR
- Author
-
Riaz, M, Certal, V, Nigam, G, Abdullatif, J, Zaghi, S, Kushida, CA, and Camacho, M
- Subjects
Positive-Pressure Respiration ,Sleep Apnea, Obstructive ,Apneia do Sono Tipo Obstrutiva ,Respiração com Pressão Positiva - Abstract
Objective. To quantify the effectiveness of nasal expiratory positive airway pressure (nasal EPAP) devices or Provent as treatment for obstructive sleep apnea (OSA). Methods. PubMed and six other databases were searched through November 15, 2015, without language limitations. Results. Eighteen studies (920 patients) were included. Pre- and post-nasal EPAP means ± standard deviations (M ± SD) for apnea-hypopnea index (AHI) in 345 patients decreased from 27.32 ± 22.24 to 12.78 ± 16.89 events/hr (relative reduction = 53.2%). Random effects modeling mean difference (MD) was -14.78 events/hr [95% CI -19.12, -10.45], p value < 0.00001. Oxygen desaturation index (ODI) in 247 patients decreased from 21.2 ± 19.3 to 12.4 ± 14.1 events/hr (relative reduction = 41.5%, p value < 0.00001). Lowest oxygen saturation (LSAT) M ± SD improved in 146 patients from 83.2 ± 6.8% to 86.2 ± 11.1%, MD 3 oxygen saturation points [95% CI 0.57, 5.63]. Epworth Sleepiness Scale (ESS) M ± SD improved (359 patients) from 9.9 ± 5.3 to 7.4 ± 5.0, MD -2.5 [95% CI -3.2, -1.8], p value < 0.0001. Conclusion. Nasal EPAP (Provent) reduced AHI by 53.2%, ODI by 41.5% and improved LSAT by 3 oxygen saturation points. Generally, there were no clear characteristics (demographic factors, medical history, and/or physical exam finding) that predicted favorable response to these devices. However, limited evidence suggests that high nasal resistance could be associated with treatment failure. Additional studies are needed to identify demographic and polysomnographic characteristics that would predict therapeutic success with nasal EPAP (Provent).
- Published
- 2015
12. Tissue-Sparing Uvulopalatopharyngoplasty for OSA: Conservative, Compassionate and Possibly just as Effective
- Author
-
Camacho, M., primary, Certal, V., additional, Modi, R., additional, and Capasso, R., additional
- Published
- 2015
- Full Text
- View/download PDF
13. Definition of a core set of quality indicators for the assessment of HIV/AIDS clinical care
- Author
-
Catumbela, E, Certal, V, Freitas, A, Costa, Carlos, Sarmento, A, Pereira, A, Escola Nacional de Saúde Pública (ENSP), and Centro de Malária e outras Doenças Tropicais (CMDT)
- Subjects
SDG 3 - Good Health and Well-being - Abstract
Made available in DSpace on 2018-03-09T23:00:38Z (GMT). No. of bitstreams: 0 Previous issue date: 2013-01-01 publishersversion published
- Published
- 2013
14. Smartphone apps for snoring
- Author
-
Camacho, M, primary, Robertson, M, additional, Abdullatif, J, additional, Certal, V, additional, Kram, Y A, additional, Ruoff, C M, additional, Brietzke, S E, additional, and Capasso, R, additional
- Published
- 2015
- Full Text
- View/download PDF
15. Nasopharyngeal airway stenting devices for obstructive sleep apnoea: A systematic review and meta-analysis
- Author
-
Kumar, A R, primary, Guilleminault, C, additional, Certal, V, additional, Li, D, additional, Capasso, R, additional, and Camacho, M, additional
- Published
- 2014
- Full Text
- View/download PDF
16. Clinical and histopathological prognostic factors in locoregional advanced laryngeal cancer.
- Author
-
Santos, T S, Estêvão, R, Antunes, L, Certal, V, Silva, J C, and Monteiro, E
- Subjects
LARYNGEAL tumors ,HISTOLOGY ,MULTIVARIATE analysis ,PROBABILITY theory ,SQUAMOUS cell carcinoma ,RETROSPECTIVE studies ,DISEASE progression ,TUMOR grading ,PROGNOSIS - Abstract
Objective:To evaluate the clinical and histopathological factors affecting the prognosis of patients with squamous cell locoregional advanced laryngeal cancer.Methods:A retrospective chart review was conducted of 121 patients with locoregional advanced laryngeal cancer, primarily treated with surgery from 2007 to 2011. Disease-free survival and overall survival rates were analysed as oncological outcomes. Prognostic variables, namely gender, pharyngeal invasion, pathological assessment of tumour and nodal stage, adjuvant therapy, margin status, nodal extracapsular extension, tumour differentiation, lymphovascular and perineural invasion, and predominant growth pattern, were also analysed.Results:One-year and three-year disease-free survival rates were 81.3 per cent and 63.5 per cent, respectively. One-year and three-year overall survival rates were 88.3 per cent and 61.4 per cent, respectively. Multivariate analysis showed that nodal extracapsular extension (p < 0.05) and an infiltrative growth pattern (p < 0.05) were associated with disease progression. Nodal extracapsular extension (p < 0.05) was associated with higher mortality.Conclusion:Nodal extracapsular extension and an infiltrative growth pattern were the main prognostic factors in locoregional advanced laryngeal cancer. The presence of pharyngeal invasion, pathologically confirmed node-positive stage 2–3 disease, close or microscopic positive margins, and lymphovascular and perineural invasion have a negative impact on prognosis. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
17. Discovery and Optimization of Pyrimidone Indoline Amide PI3Kbeta Inhibitors for the Treatment of Phosphatase and TENsin homologue (PTEN)-Deficient Cancers
- Author
-
Certal, V., primary, Carry, J.C., additional, Halley, F., additional, Virone-Oddos, A., additional, Thompson, F., additional, Filoche-Romme, B., additional, El-Ahmad, Y., additional, Karlsson, A., additional, Charrier, V., additional, Delorme, C., additional, Rak, A., additional, Abecassis, P.Y., additional, Amara, C., additional, Vincent, L., additional, Bonnevaux, H., additional, Nicolas, J.P., additional, Mathieu, M., additional, Bertrand, T., additional, Marquette, J.P., additional, Michot, N., additional, Benard, T., additional, Perrin, M.A., additional, Perron, S., additional, Monget, S., additional, Gruss-Leleu, F., additional, Doerflinger, G., additional, Guizani, H., additional, Brollo, M., additional, Delbarre, L., additional, Bertin, L., additional, Richepin, P., additional, Loyau, V., additional, Garcia-Echeverria, C., additional, Lengauer, C., additional, and Schio, L., additional
- Published
- 2014
- Full Text
- View/download PDF
18. Suture trans-septale comme alternative au méchage conventionnelle : révision systématique et méta-analyse
- Author
-
Certal, V., primary, Silva, H., additional, Santos, T., additional, Correia, A., additional, and Carvalho, C., additional
- Published
- 2012
- Full Text
- View/download PDF
19. Discovery and Optimization of New Benzimidazole- and Benzoxazole-Pyrimidone Selective PI3KBeta Inhibitors for the Treatment of Phosphatase and TENsin homologue (PTEN)-Deficient Cancers
- Author
-
Certal, V., primary, Halley, F., additional, Virone-Oddos, A., additional, Delorme, C., additional, Karlsson, A., additional, Rak, A., additional, Thompson, F., additional, Filoche-Romme, B., additional, El-Ahmad, Y., additional, Carry, J.C., additional, Abecassis, P.Y., additional, Lejeune, P., additional, Bonnevaux, H., additional, Nicolas, J.P., additional, Bertrand, T., additional, Marquette, J.P., additional, Michot, N., additional, Benard, T., additional, Below, P., additional, Vade, I., additional, Chatreaux, F., additional, Lebourg, G., additional, Pilorge, F., additional, Angouillant-Boniface, O., additional, Louboutin, A., additional, Lengauer, C., additional, and Schio, L., additional
- Published
- 2012
- Full Text
- View/download PDF
20. Trans-septal suturing technique in septoplasty: a systematic review and meta-analysis
- Author
-
Certal, V., primary, Silva, H., additional, Santos, T., additional, Correia, A., additional, and Carvalho, C., additional
- Published
- 2012
- Full Text
- View/download PDF
21. Nasopharyngeal airway stenting devices for obstructive sleep apnoea: A systematic review and meta-analysis.
- Author
-
Kumar, A R, Guilleminault, C, Certal, V, Li, D, Capasso, R, and Camacho, M
- Subjects
SLEEP apnea syndrome treatment ,AIRWAY (Anatomy) ,ACTIVE oxygen in the body ,CONFIDENCE intervals ,INFORMATION storage & retrieval systems ,MEDICAL databases ,MEDLINE ,META-analysis ,NASOPHARYNX ,SURGICAL stents ,SYSTEMATIC reviews ,DATA analysis software ,DESCRIPTIVE statistics - Abstract
Objective:To systematically review outcomes of adults with obstructive sleep apnoea treated with nasopharyngeal airway stenting devices.Methods:Medline, Scopus, Web of Science and the Cochrane Library databases were searched, and data on device use and tolerability, sleepiness, oxygen saturation, apnoea index, apnoea–hypopnoea index, and sleep quality were collected.Results:Of 573 potential studies, 29 were retrieved for detailed evaluation and 16 met the study criteria. Polysomnography data for patients treated with nasal trumpets as an isolated therapy were pooled for meta-analysis. The mean apnoea index ± standard deviation, for 53 patients, decreased from 32.4 ± 15.9 to 9.0 ± 7.2 episodes per hour (p < 0.00001). The mean apnoea–hypopnoea index, for 193 patients, decreased from 44.1 ± 18.9 to 22.7 ± 19.3 episodes per hour (p < 0.00001). The mean lowest oxygen saturation, for 193 patients, increased from 66.5 ± 14.2 to 75.5 ± 13.9 per cent (p < 0.00001).Conclusion:Some studies have demonstrated limited effectiveness and low tolerability of nasopharyngeal airway stenting devices, while other studies have shown a significant benefit in treating obstructive sleep apnoea, with a high level of patient acceptance. Nasal trumpets have been successful in decreasing airway obstruction in the short term. [ABSTRACT FROM PUBLISHER]
- Published
- 2015
- Full Text
- View/download PDF
22. Functionalized dihydropyridines do reduce alkoxycarbene complexes of chromium and give access to polycyclic butenolides
- Author
-
Rudler, H., Parlier, A., Certal, V., and Frison, J. C.
- Published
- 2001
- Full Text
- View/download PDF
23. Optimization of the Antibacterial Spectrum and the Developability Profile of the Novel-Class Natural Product Corramycin.
- Author
-
Renard S, Versluys S, Taillier T, Dubarry N, Leroi-Geissler C, Rey A, Cornaire E, Sordello S, Carry JB, Angouillant-Boniface O, Gouyon T, Thompson F, Lebourg G, Certal V, Balazs L, Arranz E, Doerflinger G, Bretin F, Gervat V, Brohan E, Kraft V, Boulenc X, Ducelier C, Bacqué E, and Couturier C
- Subjects
- Mice, Animals, Gram-Negative Bacteria, Bacteria, Microbial Sensitivity Tests, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use, Anti-Bacterial Agents chemistry, Escherichia coli Infections
- Abstract
Corramycin 1 is a novel zwitterionic antibacterial peptide isolated from a culture of the myxobacterium Corallococcus coralloides . Though Corramycin displayed a narrow spectrum and modest MICs against sensitive bacteria, its ADMET and physchem profile as well as its high tolerability in mice along with an outstanding in vivo efficacy in an Escherichia coli septicemia mouse model were promising and prompted us to embark on an optimization program aiming at enlarging the spectrum and at increasing the antibacterial activities by modulating membrane permeability. Scanning the peptidic moiety by the Ala-scan strategy followed by key stabilization and introduction of groups such as a primary amine or siderophore allowed us to enlarge the spectrum and increase the overall developability profile. The optimized Corramycin 28 showed an improved mouse IV PK and a broader spectrum with high potency against key Gram-negative bacteria that translated into excellent efficacy in several in vivo mouse infection models.
- Published
- 2023
- Full Text
- View/download PDF
24. Targeted Hypoglossal Nerve Stimulation for Patients With Obstructive Sleep Apnea: A Randomized Clinical Trial.
- Author
-
Schwartz AR, Jacobowitz O, Eisele DW, Mickelson SA, Miller MB, Oliven A, Certal V, Hopp ML, Winslow DH, Huntley TC, Nachlas NE, Pham LV, Gillespie MB, Weeks BH, Lovett EG, Shen J, Malhotra A, and Maurer JT
- Subjects
- Humans, Female, Middle Aged, Male, Hypoglossal Nerve physiopathology, Quality of Life, Sleepiness, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive physiopathology, Sleep Apnea Syndromes
- Abstract
Importance: Evidence is lacking from randomized clinical trials of hypoglossal nerve stimulation in obstructive sleep apnea (OSA)., Objective: To evaluate the safety and effectiveness of targeted hypoglossal nerve stimulation (THN) of the proximal hypoglossal nerve in patients with OSA., Design, Setting, and Participants: This randomized clinical trial (THN3) was conducted at 20 centers and included 138 patients with moderate to severe OSA with an apnea-hypopnea index (AHI) of 20 to 65 events per hour and body mass index (calculated as weight in kilograms divided by height in meters squared) of 35 or less. The trial was conducted from May 2015 through June 2018. Data were analyzed from January 2022 through January 2023., Intervention: Implant with THN system; randomized 2:1 to activation at month 1 (treatment) or month 4 (control). All received 11 months of THN with follow-up at months 12 and 15, respectively., Main Outcomes and Measures: Primary effectiveness end points comprised AHI and oxygen desaturation index (ODI) responder rates (RRs). Treatment responses at months 4 and 12/15 were defined as a 50% or greater reduction in AHI to 20 or less per hour and an ODI decrease of 25% or greater. Coprimary end points comprised (1) month 4 AHI and ODI RR in the treatment greater than the control group and (2) month 12/15 AHI and ODI RR in the entire cohort exceeding 50%. Secondary end points included sleep apnea severity (AHI and ODI) and patient-reported outcomes (Epworth Sleepiness Scale, Functional Outcomes of Sleep Questionnaire, and EQ-5D visual analog scale)., Results: Among 138 participants, the mean (SD) age was 56 (9) years, and 19 (13.8%) were women. Month 4 THN RRs were substantially greater in those in the treatment vs control group (AHI, 52.3% vs 19.6%; ODI, 62.5% vs 41.3%, respectively) with treatment-control standardized mean differences of 0.725 (95% CI, 0.360-1.163) and 0.434 (95% CI, 0.070-0.843) for AHI and ODI RRs, respectively. Months 12/15 RRs were 42.5% and 60.4% for AHI and ODI, respectively. Improvements in AHI, ODI, Epworth Sleepiness Scale, Functional Outcomes of Sleep Questionnaire, and EQ-5D visual analog scale scores were all clinically meaningful (medium to large effect size). Two serious adverse events and 100 nonserious related adverse events were observed from the implant procedure or study protocol., Conclusions and Relevance: This randomized clinical trial found that THN demonstrated improvements in sleep apnea, sleepiness, and quality of life in patients with OSAs over an extended AHI and body mass index range without prior knowledge of pharyngeal collapse pattern. Clinically meaningful improvements in AHI and patient-reported responses compared favorably with those of distal hypoglossal nerve stimulation trials, although clinically meaningful differences were not definitive for ODI., Trial Registration: ClinicalTrials.gov Identifier: NCT02263859.
- Published
- 2023
- Full Text
- View/download PDF
25. SAR439859, a Novel Selective Estrogen Receptor Degrader (SERD), Demonstrates Effective and Broad Antitumor Activity in Wild-Type and Mutant ER-Positive Breast Cancer Models.
- Author
-
Shomali M, Cheng J, Sun F, Koundinya M, Guo Z, Hebert AT, McManus J, Levit MN, Hoffmann D, Courjaud A, Arrebola R, Cao H, Pollard J, Lee JS, Besret L, Caron A, Bangari DS, Abecassis PY, Schio L, El-Ahmad Y, Halley F, Tabart M, Certal V, Thompson F, McCort G, Filoche-Rommé B, Cheng H, Garcia-Echeverria C, Debussche L, and Bouaboula M
- Subjects
- Animals, Disease Models, Animal, Female, Humans, Mice, Breast Neoplasms drug therapy, Receptors, Estrogen therapeutic use
- Abstract
Primary treatment for estrogen receptor-positive (ER+) breast cancer is endocrine therapy. However, substantial evidence indicates a continued role for ER signaling in tumor progression. Selective estrogen receptor degraders (SERD), such as fulvestrant, induce effective ER signaling inhibition, although clinical studies with fulvestrant report insufficient blockade of ER signaling, possibly due to suboptimal pharmaceutical properties. Furthermore, activating mutations in the ER have emerged as a resistance mechanism to current endocrine therapies. New oral SERDs with improved drug properties are under clinical investigation, but the biological profile that could translate to improved therapeutic benefit remains unclear. Here, we describe the discovery of SAR439859, a novel, orally bioavailable SERD with potent antagonist and degradation activities against both wild-type and mutant Y537S ER. Driven by its fluoropropyl pyrrolidinyl side chain, SAR439859 has demonstrated broader and superior ER antagonist and degrader activities across a large panel of ER+ cells, compared with other SERDs characterized by a cinnamic acid side chain, including improved inhibition of ER signaling and tumor cell growth. Similarly, in vivo treatment with SAR439859 demonstrated significant tumor regression in ER+ breast cancer models, including MCF7- ESR1 wild-type and mutant-Y537S mouse tumors, and HCI013, a patient-derived tamoxifen-resistant xenograft tumor. These findings indicate that SAR439859 may provide therapeutic benefit to patients with ER+ breast cancer, including those who have resistance to endocrine therapy with both wild-type and mutant ER., (©2020 American Association for Cancer Research.)
- Published
- 2021
- Full Text
- View/download PDF
26. The Value of Oxygen Desaturation Index for Diagnosing Obstructive Sleep Apnea: A Systematic Review.
- Author
-
Rashid NH, Zaghi S, Scapuccin M, Camacho M, Certal V, and Capasso R
- Subjects
- Adult, Aged, Body Mass Index, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Factors, Sensitivity and Specificity, Hypoxia diagnosis, Oxygen Consumption, Polysomnography statistics & numerical data, Severity of Illness Index, Sleep Apnea, Obstructive diagnosis
- Abstract
Objectives: Intermittent hypoxemia is a risk factor for developing complications in obstructive sleep apnea (OSA) patients. The objective of this systematic review was to identify articles evaluating the accuracy of the oxygen desaturation index (ODI) as compared with the apnea-hypopnea index (AHI) and then provide possible values to use as a cutoff for diagnosing adult OSA., Study Design: Systematic Review of Literature., Methods: PubMed, the Cochrane Library, and SCOPUS databases were searched through November 2019., Results: Eight studies (1,924 patients) met criteria (age range: 28-70.9 years, body mass index range: 21.9-37 kg/m
2 , and AHI range: 0.5-62 events/hour). Five studies compared ODI and AHI simultaneously, and three had a week to months between assessments. Sensitivities ranged from 32% to 98.5%, whereas specificities ranged from 47.7% to 98%. Significant heterogeneity was present; however, for studies reporting data for a 4% ODI ≥ 15 events/hour, the specificity for diagnosing OSA ranged from 75% to 98%, and only one study reported the positive predictive value, which was 97%. Direct ODI and AHI comparisons were not made because of different hypopnea scoring, different oxygen desaturation categories, and different criteria for grading OSA severity., Conclusion: Significant heterogeneity exists in studies comparing ODI and AHI. Based on currently published studies, consideration should be given for diagnosing adult OSA with a 4% ODI of ≥ 15 events/hour and for recommending further evaluation for diagnosing OSA with a 4% ODI ≥ 10 events/hour. Screening with oximetry may be indicated for the detection of OSA in select patients. Further study is needed before a definitive recommendation can be made. Laryngoscope, 131:440-447, 2021., (Published 2020. This article is a U.S. Government work and is in the public domain in the USA.)- Published
- 2021
- Full Text
- View/download PDF
27. Discovery of 6-(2,4-Dichlorophenyl)-5-[4-[(3 S )-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7 H -benzo[7]annulene-2-carboxylic acid (SAR439859), a Potent and Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen-Receptor-Positive Breast Cancer.
- Author
-
El-Ahmad Y, Tabart M, Halley F, Certal V, Thompson F, Filoche-Rommé B, Gruss-Leleu F, Muller C, Brollo M, Fabien L, Loyau V, Bertin L, Richepin P, Pilorge F, Desmazeau P, Girardet C, Beccari S, Louboutin A, Lebourg G, Le-Roux J, Terrier C, Vallée F, Steier V, Mathieu M, Rak A, Abecassis PY, Vicat P, Benard T, Bouaboula M, Sun F, Shomali M, Hebert A, Levit M, Cheng H, Courjaud A, Ginesty C, Perrault C, Garcia-Echeverria C, McCort G, and Schio L
- Subjects
- Animals, Breast Neoplasms metabolism, Crystallography, X-Ray, Dogs, Drug Resistance, Neoplasm, Female, Half-Life, High-Throughput Screening Assays, Humans, Ligands, Mice, Models, Molecular, Rats, Receptors, Estrogen drug effects, Selective Estrogen Receptor Modulators pharmacokinetics, Selective Estrogen Receptor Modulators pharmacology, Structure-Activity Relationship, Xenograft Model Antitumor Assays, Breast Neoplasms drug therapy, Drug Discovery methods, Pyrrolidines chemical synthesis, Pyrrolidines pharmacology, Receptors, Estrogen metabolism, Selective Estrogen Receptor Modulators therapeutic use
- Abstract
More than 75% of breast cancers are estrogen receptor alpha (ERα) positive (ER+), and resistance to current hormone therapies occurs in one-third of ER+ patients. Tumor resistance is still ERα-dependent, but mutations usually confer constitutive activation to the hormone receptor, rendering ERα modulator drugs such as tamoxifen and aromatase inhibitors ineffective. Fulvestrant is a potent selective estrogen receptor degrader (SERD), which degrades the ERα receptor in drug-resistant tumors and has been approved for the treatment of hormone-receptor-positive metastatic breast cancer following antiestrogen therapy. However, fulvestrant shows poor pharmacokinetic properties in human, low solubility, weak permeation, and high metabolism, limiting its administration to inconvenient intramuscular injections. This Drug Annotation describes the identification and optimization of a new series of potent orally available SERDs, which led to the discovery of 6-(2,4-dichlorophenyl)-5-[4-[(3 S )-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7 H -benzo[7]annulene-2-carboxylic acid ( 43d ), showing promising antitumor activity in breast cancer mice xenograft models and whose properties warranted clinical evaluation.
- Published
- 2020
- Full Text
- View/download PDF
28. Rapid maxillary expansion for pediatric obstructive sleep apnea: A systematic review and meta-analysis.
- Author
-
Camacho M, Chang ET, Song SA, Abdullatif J, Zaghi S, Pirelli P, Certal V, and Guilleminault C
- Subjects
- Adenoidectomy, Child, Child, Preschool, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Male, Oxygen blood, Postoperative Complications blood, Postoperative Complications diagnosis, Sleep Apnea, Obstructive blood, Sleep Apnea, Obstructive diagnosis, Tonsillectomy, Palatal Expansion Technique, Sleep Apnea, Obstructive surgery
- Abstract
Objectives/hypothesis: To perform a systematic review with meta-analysis for sleep study outcomes in children who have undergone rapid maxillary expansion (RME) as treatment for obstructive sleep apnea (OSA)., Data Sources: PubMed/MEDLINE and eight additional databases., Review Methods: Three authors independently and systematically reviewed the international literature through February 21, 2016., Results: Seventeen studies reported outcomes for 314 children (7.6 ± 2.0 years old) with high-arched and/or narrow hard palates (transverse maxillary deficiency) and OSA. Data were analyzed based on follow-up duration: ≤3 years (314 patients) and >3 years (52 patients). For ≤3-year follow-up, the pre- and post-RME apnea-hypopnea index (AHI) decreased from a mean ± standard deviation (M ± SD) of 8.9 ± 7.0/hr to 2.7 ± 3.3/hr (70% reduction). The cure rate (AHI <1/hr) for 90 patients for whom it could be calculated was 25.6%. Random effects modeling for AHI standardized mean difference (SMD) is -1.54 (large effect). Lowest oxygen saturation (LSAT) improved from 87.0 ± 9.1% to 96.0 ± 2.7%. Random effects modeling for LSAT SMD is 1.74 (large effect). AHI improved more in children with previous adenotonsillectomy or small tonsils (73-95% reduction) than in children with large tonsils (61% reduction). For >3-year follow-up (range = 6.5-12 years), the AHI was reduced from an M ± SD of 7.1 ± 5.7/hr to 1.5 ± 1.8/hr (79% reduction)., Conclusions: Improvement in AHI and lowest oxygen saturation has consistently been seen in children undergoing RME, especially in the short term (<3-year follow-up). Randomized trials and more studies reporting long-term data (≥3-year follow-up) would help determine the effect of growth and spontaneous resolution of OSA. Laryngoscope, 2016 Laryngoscope, 127:1712-1719, 2017., (© 2016 The American Laryngological, Rhinological and Otological Society, Inc.)
- Published
- 2017
- Full Text
- View/download PDF
29. Genial tubercle advancement and genioplasty for obstructive sleep apnea: A systematic review and meta-analysis.
- Author
-
Song SA, Chang ET, Certal V, Del Do M, Zaghi S, Liu SY, Capasso R, and Camacho M
- Subjects
- Female, Follow-Up Studies, Humans, Male, Mandibular Advancement methods, Polysomnography, Severity of Illness Index, Sleep Apnea, Obstructive diagnosis, Sleep Apnea, Obstructive psychology, Treatment Outcome, Genioplasty methods, Quality of Life, Sleep Apnea, Obstructive surgery
- Abstract
Objective: To perform a systematic review and meta-analysis for studies evaluating genioplasty alone, genial tubercle advancement (GTA) alone, and GTA with hyoid surgery (GTA-HS) to treat obstructive sleep apnea (OSA)., Data Sources: Ten databases., Review Methods: Three authors searched through November 15, 2015., Results: 1,207 studies were screened; 69 were downloaded; and 13 studies met inclusion criteria. A total of 111 patients were included, with 27 standard genioplasty, 10 modified genioplasty, 24 GTA, and 50 GTA-HS patients. For standard genioplasty, the apnea-hypopnea index (AHI) reduced from a mean ± standard deviation (M ± SD) of 18.8 ± 3.8 (95% confidence interval [CI] 17.6, 20.0) to 10.8 ± 4.0 (95% CI 9.5, 12.1) events/hour (relative reduction 43.8%), P value = 0.0001. Genioplasty improved lowest oxygen saturation (LSAT) from 82.3 ± 7.3% (95% CI 80.0, 84.7) to 86.8 ± 5.2% (95% CI 85.1, 88.5), P value = 0.0032. For modified genioplasty AHI increased by 37.3%. For GTA, the AHI reduced from an M ± SD of 37.6 ± 24.2 (95% CI 27.9, 47.3) to 20.4 ± 15.1 (95% CI 14.4, 26.4) events/hour (relative reduction 45.7%), P value = 0.0049. GTA improved LSAT from 83.1 ± 8.3% (95% CI 79.8, 86.4) to 85.5 ± 6.8% (95% CI 82.8, 88.2), P value = 0.2789. For GTA-HS, the AHI reduced from an M ± SD of 34.5 ± 22.1 (95% CI 28.4, 40.6) to 15.3 ± 17.6 (95% CI 10.4, 20.2) events/hour (relative reduction 55.7%), P value < 0.0001; GTA-HS improved LSAT from 80.1 ± 16.6% (95% CI 75.5, 84.7) to 88.3 ± 6.9% (95% CI 86.4, 90.2), P value = 0.0017., Conclusion: Standard genioplasty, GTA and GTA-HS can improve OSA outcomes such as AHI and LSAT. Given the low number of studies, these procedures remain as an area for additional OSA research. Laryngoscope, 127:984-992, 2017., (© 2017 The American Laryngological, Rhinological and Otological Society, Inc.)
- Published
- 2017
- Full Text
- View/download PDF
30. Updated Concepts on Treatment Outcomes for Obstructive Sleep Apnea.
- Author
-
Certal V and Capasso R
- Subjects
- Humans, Polysomnography, Sleep Apnea, Obstructive diagnosis, Snoring therapy, Treatment Outcome, Sleep Apnea, Obstructive therapy
- Abstract
Obstructive sleep apnea is a highly prevalent and poorly understood condition that not only leads to significant individual patient health damage, but carries a large societal cost secondary to excessive healthcare utilization, motor-vehicle accidents, and work absenteeism. While a significant fund of knowledge about its damaging effects on the cardiovascular system and neural pathways has been gathered over the past few decades, the translation to direct patient care still presents numerous challenges. With the exception of clear issues such as socially unacceptable snoring and breathing irregularities, the exact cause and effect relationship between airway narrowing, hypoxemia, and sleep fragmentation with subjective sleep-related complaints and neurocognitive symptoms is less clear. Besides better-defined clinical diagnostic criteria, the need for clear serum, saliva, or urine biomarkers to assess the physiologic burden of disease remains a work in progress, as are well-defined long-term clinically relevant outcomes of interest. Here, readers will be guided to a critical evaluation on the current main metrics of sleep study, suggested steps on diagnostic and treatment goals, and introduced to the concept of a continuum of disease., (© 2017 S. Karger AG, Basel.)
- Published
- 2017
- Full Text
- View/download PDF
31. Introducing a new concept in obstructive sleep apnea: The continuum of treatment.
- Author
-
Certal V, Camacho M, Song SA, and Capasso R
- Subjects
- Humans, Positive-Pressure Respiration, Sleep Apnea, Obstructive diagnosis, Sleep Apnea, Obstructive physiopathology, Snoring, Sleep Apnea, Obstructive therapy
- Published
- 2017
- Full Text
- View/download PDF
32. Expansion sphincter pharyngoplasty for obstructive sleep apnea: an update to the recent meta-analysis.
- Author
-
Camacho M, Zaghi S, Piccin O, and Certal V
- Subjects
- Humans, Pharynx, Sleep Apnea, Obstructive
- Published
- 2016
- Full Text
- View/download PDF
33. Tonsillectomy for adult obstructive sleep apnea: A systematic review and meta-analysis.
- Author
-
Camacho M, Li D, Kawai M, Zaghi S, Teixeira J, Senchak AJ, Brietzke SE, Frasier S, and Certal V
- Subjects
- Adult, Humans, Sleep Apnea, Obstructive surgery, Tonsillectomy
- Abstract
Objectives/hypothesis: To determine if sleepiness and sleep study variables (e.g., Apnea-Hypopnea Index [AHI] and lowest oxygen saturation) improve following isolated tonsillectomy for adult obstructive sleep apnea (OSA)., Study Design: Systematic review and meta-analysis., Methods: Nine databases (PubMed/MEDLINE included) were searched through November 24, 2015., Results: Seventeen studies (n = 216 patients, 34.4 ± 10.0 years and body mass index: 29.0 ± 6.1 kg/m(2) ) met criteria. Tonsils sizes were hypertrophied, large, enlarged, extremely enlarged, or grades 2 to 4. Apnea-Hypopnea Index decreased by 65.2% (from 40.5 ± 28.9/hour to 14.1 ± 17.1/hour) (n = 203). The AHI mean difference (MD) was -30.2 per hour (95% confidence interval [CI] -39.3, -21.1) (P value < 0.00001). The AHI SMD was -1.37 (-1.65, -1.09) (large effect). Lowest oxygen saturation improved from 77.7 ± 11.9% to 85.5 ± 8.2% (n = 186). Lowest oxygen saturation MD was 8.5% (95% CI 5.2, 11.8) (P value < 0.00001). The Epworth Sleepiness Scale decreased from 11.6 ± 3.7 to 6.1 ± 3.9 (P value < 0.00001) (n = 125). Individual patient outcomes (n = 54) demonstrated an 85.2% success rate (AHI < 20/hour and ≥ 50% reduction) and a 57.4% cure rate. Individual patient data meta-analysis showed preoperative AHI < 30 per hour to be a significant predictor of surgical success (P value < 0.001) and cure (P value = 0.043); among patients with preoperative AHI < 30 per hour, tonsillectomy success rate was 100% (25 of 25) and cure rate was 84% (21 of 25) with a mean postoperative AHI of 2.4 ± 2.1 per hour; this compares to tonsillectomy success rate of 72.4% (21 of 29), cure rate of 10 of 29 (34.4%), and mean postoperative AHI of 14.3 ± 13.9 per hour for patients with preoperative AHI ≥ 30 per hour., Conclusion: Isolated tonsillectomy can be successful as treatment for adult OSA, especially among patients with large tonsils and mild to moderate OSA (AHI < 30/hour). Laryngoscope, 2016 Laryngoscope, 126:2176-2186, 2016., (© 2016 The American Laryngological, Rhinological and Otological Society, Inc.)
- Published
- 2016
- Full Text
- View/download PDF
34. Hyoid surgery alone for obstructive sleep apnea: A systematic review and meta-analysis.
- Author
-
Song SA, Wei JM, Buttram J, Tolisano AM, Chang ET, Liu SY, Certal V, and Camacho M
- Subjects
- Humans, Treatment Outcome, Hyoid Bone surgery, Sleep Apnea, Obstructive surgery
- Abstract
Objectives/hypothesis: The primary objective was to determine if sleep study variables (e.g., apnea-hypopnea index [AHI] and lowest oxygen saturation) and quantitative sleepiness data improve following isolated hyoid surgery for obstructive sleep apnea (OSA)., Study Design: Systematic review and meta-analysis., Methods: Nine databases, including PubMed, were searched through September 5, 2015., Results: Four hundred ninety-eight studies were screened, 64 were reviewed, and nine studies met inclusion criteria. A total of 101 patients were identified who underwent hyoid surgery alone for treatment of OSA. Subanalyses were performed for: 1) type of surgery, 2) primary versus secondary hyoid surgery, 3) positional versus nonpositional OSA, 4) age, and 5) body mass index. In patients undergoing isolated hyoid surgery, the AHI decreased from a mean ± standard deviation of 37.3 ± 21.1 (95% confidence interval [CI]: 33.1, 41.5) to 23.0 ± 18.6 (95% CI: 19.3, 26.7) events/hour, which correspond to a 38.3% reduction (P < .0001). AHI reduced by 38.3% for hyoid myotomy with suspension, by 50.7% for hyothyroidopexy, and by 7.1% for hyoid expansion. The Epworth Sleepiness Scale decreased by 3.2 points from 10.3 ± 4.9 (95% CI: 8.8, 11.8) to 7.1 ± 4.2 (95% CI: 5.8, 8.4; P = .0027)., Conclusions: Isolated hyoid surgery has reduced OSA severity and improved sleepiness in adults. Hyothyroidopexy provided a 50.7% reduction in AHI, followed by hyoid myotomy with suspension (38.3% reduction in AHI) and hyoid expansion (7.1% reduction in AHI). The current literature lacks high-quality evidence with regard to hyoid surgery, and additional studies are needed to further elucidate the effect of hyoid surgery in OSA., Level of Evidence: NA Laryngoscope, 126:1702-1708, 2016., (© 2016 The American Laryngological, Rhinological and Otological Society, Inc.)
- Published
- 2016
- Full Text
- View/download PDF
35. Supraglottoplasty for laryngomalacia with obstructive sleep apnea: A systematic review and meta-analysis.
- Author
-
Camacho M, Dunn B, Torre C, Sasaki J, Gonzales R, Liu SY, Chan DK, Certal V, and Cable BB
- Subjects
- Child, Glottis surgery, Humans, Laryngomalacia complications, Oxygen blood, Sleep Apnea, Obstructive etiology, Treatment Outcome, Laryngeal Muscles surgery, Laryngomalacia surgery, Sleep Apnea, Obstructive surgery
- Abstract
Objectives/hypothesis: To determine if apnea-hypopnea index (AHI) and lowest oxygen saturation (LSAT) improve following isolated supraglottoplasty for laryngomalacia with obstructive sleep apnea (OSA) in children., Study Design: Systematic review and meta-analysis., Methods: Nine databases, including PubMed/MEDLINE, were searched through September 30, 2015., Results: A total of 517 studies were screened; 57 were reviewed; and 13 met criteria. One hundred thirty-eight patients were included (age range: 1 month-12.6 years). Sixty-four patients had sleep exclusive laryngomalacia, and in these patients: 1) AHI decreased from a mean (M) ± standard deviation (SD) of 14.0 ± 16.5 (95% confidence interval [CI] 10.0, 18.0) to 3.3 ± 4.0 (95% CI 2.4, 4.4) events/hour (relative reduction: 76.4% [95% CI 53.6, 106.4]); 2) LSAT improved from a M ± SD of 84.8 ± 8.4% (95% CI 82.8, 86.8) to 87.6 ± 4.4% (95% CI 86.6, 88.8); 3) standardized mean differences (SMD) demonstrated a small effect for LSAT and a large effect for AHI; and 4) cure (AHI < 1 event/hour) was 10.5% (19 patients with individual data). Seventy-four patients had congenital laryngomalacia, and in these patients: 1) AHI decreased from a M ± SD of 20.4 ± 23.9 (95% CI 12.8, 28.0) to 4.0 ± 4.5 (95% CI 2.6, 5.4) events/hour (relative reduction: 80.4% [95% CI 46.6, 107.4]); 2) LSAT improved from a M ± SD of 74.5 ± 11.9% (95% CI 70.9, 78.1) to 88.4 ± 6.6% (95% CI 86.4, 90.4); 3) SMD demonstrated a large effect for both AHI and LSAT; and 4) cure was 26.5% (38 patients with individual data)., Conclusion: Supraglottoplasty has improved AHI and LSAT in children with OSA and either sleep exclusive laryngomalacia or congenital laryngomalacia; however, the majority of them are not cured. Laryngoscope, 126:1246-1255, 2016., (© 2015 The American Laryngological, Rhinological and Otological Society, Inc.)
- Published
- 2016
- Full Text
- View/download PDF
36. Maxillary expansion and maxillomandibular expansion for adult OSA: A systematic review and meta-analysis.
- Author
-
Abdullatif J, Certal V, Zaghi S, Song SA, Chang ET, Gillespie MB, and Camacho M
- Subjects
- Humans, Oxygen blood, Polysomnography, Severity of Illness Index, Palatal Expansion Technique, Sleep Apnea, Obstructive therapy
- Abstract
Objective: This study sought to systematically review the international literature for articles evaluating maxillary expansion and maxillomandibular expansion as treatments for obstructive sleep apnea (OSA) in adults and to perform a meta-analysis., Data Sources: Nine databases (including MEDLINE/PubMed)., Review Methods: Searches were performed through January 8, 2016. The PRISMA statement was followed., Results: Eight adult studies (39 patients) reported polysomnography and/or sleepiness outcomes. Six studies reported outcomes for maxillary expansion (36 patients), and the apnea-hypopnea index (AHI) decreased from a mean (M) ± standard deviation (SD) of 24.3 ± 27.5 [95% CI 15.3, 33.3] to 9.9 ± 13.7 [95% CI 5.4, 14.4] events/hr (relative reduction: 59.3%). Maxillary expansion improved lowest oxygen saturation (LSAT) from a M ± SD of 84.3 ± 8.1% [95% CI 81.7, 87.0] to 86.9 ± 5.6% [95% CI 85.1, 88.7]. Maxillomandibular expansion was reported in two studies (3 patients) and AHI decreased from a M ± SD of 47.53 ± 29.81 [95% CI -26.5 to 121.5] to 10.7 ± 3.2 [95% CI 2.8, 18.6] events/hr (relative reduction: 77.5%). Maxillomandibular expansion improved LSAT from a M ± SD of 76.7 ± 14.5% [95% CI 40.7, 112.7] to 89.3 ± 3.1 [95% CI 81.6, 97]., Conclusion: The current literature demonstrates that maxillary expansion can improve and maxillomandibular expansion can possibly improve AHI and LSAT in adults; however, given the paucity of studies, these remain open for additional research efforts., (Copyright © 2016 European Association for Cranio-Maxillo-Facial Surgery. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
37. Five-Minute Awake Snoring Test for Determining CPAP Pressures (Five-Minute CPAP Test): A Pilot Study.
- Author
-
Camacho M, Ruoff CM, Kawai M, Modi R, Arbee J, Hekmat A, Robertson M, Zaghi S, Certal V, Capasso R, and Kushida CA
- Abstract
Objective. To develop a quick, simple, bedside test for determining continuous positive airway pressures (CPAP) for obstructive sleep apnea (OSA) patients. Study Design. Prospective case series at a tertiary medical center. Methods. The Five-Minute Awake Snoring Test for Determining CPAP (Five-Minute CPAP Test) was developed and tested. Patients wear a soft-gel nasal triangle mask while holding a tongue depressor with the wide section (1.75 cm) between the teeth. Fixed pressure nasal CPAP is applied while the patient simulates snoring at 4 centimeters of water pressure. The pressure is incrementally titrated up and then down to determine the lowest pressure at which the patient cannot snore (Quiet Pressure). Results. Overall, thirty-eight patients participated. All could simulate snoring. Correlation coefficients were statistically significant between Quiet Pressures and body mass index (r s = 0.60 [strong positive relationship], p = 0.0088), apnea-hypopnea index (r s = 0.49 [moderate positive relationship], p = 0.039), lowest oxygen saturation (r s = -0.47 [moderate negative relationship], p = 0.048), and oxygen desaturation index (r s = 0.62 [strong positive relationship], p = 0.0057). Conclusion. This pilot study introduces a new concept, which is the final product of over one year of exploration, development, and testing. Five-Minute CPAP Test is a quick, inexpensive, and safe bedside test based on supine awake simulated snoring with nasal CPAP.
- Published
- 2016
- Full Text
- View/download PDF
38. Inferior Turbinate Size and CPAP Titration Based Treatment Pressures: No Association Found among Patients Who Have Not Had Nasal Surgery.
- Author
-
Camacho M, Zaghi S, Tran D, Song SA, Chang ET, and Certal V
- Abstract
Objective. To evaluate the effect of turbinate sizes on the titrated continuous positive airway pressure (CPAP) therapeutic treatment pressures for patients with obstructive sleep apnea (OSA) who have not had nasal surgery. Study Design. Retrospective case series. Methods. A chart review was performed for 250 consecutive patients. Results. 45 patients met inclusion criteria. The mean ± standard deviation (M ± SD) for age was 54.6 ± 22.4 years and for body mass index was 28.5 ± 5.9 kg/m(2). The Spearman's rank correlation coefficient (r s ) between CPAP therapeutic treatment pressures and several variables were calculated and were weakly correlated (age r s = 0.29, nasal obstruction r s = -0.30), moderately correlated (body mass index r s = 0.42 and lowest oxygen saturation r s = -0.47), or strongly correlated (apnea-hypopnea index r s = 0.60 and oxygen desaturation index (r s = 0.62)). No statistical significance was found with one-way analysis of variance (ANOVA) between CPAP therapeutic treatment pressures and inferior turbinate size (right turbinates p value = 0.2012, left turbinate p value = 0.3064), nasal septal deviation (p value = 0.4979), or mask type (p value = 0.5136). Conclusion. In this study, CPAP titration based therapeutic treatment pressures were not found to be associated with inferior turbinate sizes; however, the CPAP therapeutic treatment pressures were strongly correlated with apnea-hypopnea index and oxygen desaturation index.
- Published
- 2016
- Full Text
- View/download PDF
39. Predictors of Nasal Obstruction: Quantification and Assessment Using Multiple Grading Scales.
- Author
-
Camacho M, Zaghi S, Certal V, Abdullatif J, Modi R, Sridhara S, Tolisano AM, Chang ET, Cable BB, and Capasso R
- Abstract
Unlabelled: Objective. To evaluate the association between nasal obstruction and (1) demographic factors, (2) medical history, (3) physical tests, and (4) nasal exam findings. Study Design., Case Series: Methods. Chart review at a tertiary medical center. Results. Two hundred-forty consecutive patients (52.1 ± 17.5 years old, with a Nasal Obstruction Symptom Evaluation (NOSE) score of 32.0 ± 24.1) were included. Demographic factors and inferior turbinate sizes were not associated with NOSE score or Nasal Obstruction Visual Analog Scale (NO-VAS). A significant association was found between higher NOSE score on univariate analysis and positive history of nasal trauma (p = 0.0136), allergic rhinitis (p < 0.0001), use of nasal steroids (p = 0.0108), higher grade of external nasal deformity (p = 0.0149), higher internal nasal septal deviation grade (p = 0.0024), and narrow internal nasal valve angle (p < 0.0001). Multivariate analysis identified the following as independent predictors of high NOSE score: NO-VAS: ≥50 (Odds Ratio (OR) = 17.6 (95% CI 5.83-61.6), p < 0.0001), external nasal deformity: grades 2-4 (OR = 4.63 (95% CI 1.14-19.9), p = 0.0339), and allergic rhinitis: yes (OR = 5.5 (95% CI 1.77-18.7), p = 0.0041). Conclusion. Allergic rhinitis, NO-VAS score ≥ 50, and external nasal deformity (grades 2-4) were statistically significant independent predictors of high NOSE scores on multivariate analysis. Inferior turbinate size was not associated with NOSE scores or NO-VAS.
- Published
- 2016
- Full Text
- View/download PDF
40. Mini Tracheostomy for Obstructive Sleep Apnea: An Evidence Based Proposal.
- Author
-
Camacho M, Zaghi S, Chang ET, Song SA, Szelestey B, and Certal V
- Abstract
Objective. To search for articles evaluating the use of tracheostomies (either permanent stomas or tracheostomy tubes) in adult obstructive sleep apnea (OSA) patients and to evaluate the potential for the use of mini tracheostomies as treatment for OSA. Study Design. Systematic review. Methods. Nine databases were searched from inception through July 21, 2015. Results. The overall tracheostomy search yielded 516 articles, of which eighteen studies provided polysomnographic data. No study was identified (empty review) for the use of mini tracheostomies for treating OSA. The mini tracheostomy search yielded ninety-five articles which describe findings for either mini tracheostomy kits (inner cannula diameter of 4 mm) or the performance of mini tracheotomies. Six articles described the use of mini tracheostomies as a temporary procedure to relieve acute upper airway obstruction and none described the use for OSA. For tracheostomy stomal sites, suturing the skin directly to the tracheal rings with defatting can minimize stomal site collapse. The smallest tracheostomy stomal size that can successfully treat OSA has not been described. Conclusion. Mini tracheostomies as small as 4 mm have been successfully used in the short term to relieve upper airway obstruction. Given that polysomnography data are lacking, additional research is needed.
- Published
- 2016
- Full Text
- View/download PDF
41. Maxillomandibular Advancement for Treatment of Obstructive Sleep Apnea: A Meta-analysis.
- Author
-
Zaghi S, Holty JE, Certal V, Abdullatif J, Guilleminault C, Powell NB, Riley RW, and Camacho M
- Subjects
- Adult, Humans, Mandibular Advancement, Sleep Apnea, Obstructive surgery
- Abstract
Importance: Maxillomandibular advancement (MMA) is an invasive yet effective surgical option for obstructive sleep apnea (OSA) that achieves enlargement of the upper airway by physically expanding the facial skeletal framework., Objective: To identify criteria associated with surgical outcomes of MMA using aggregated individual patient data from multiple studies., Data Sources: The Cochrane Library, Scopus, Web of Science, and MEDLINE from June 1, 2014, to March 16, 2015, using the Medical Subject Heading keywords maxillomandibular advancement, orthognathic surgery, maxillary osteotomy, mandibular advancement, sleep apnea, surgical, surgery, sleep apnea syndrome, and obstructive sleep apnea., Study Selection: Inclusion criteria consisted of studies in all languages of (1) adult patients who underwent MMA as treatment for OSA; (2) report of preoperative and postoperative quantitative outcomes for the apnea-hypopnea index (AHI) and/or respiratory disturbance index (RDI); and (3) report of individual patient data. Studies of patients who underwent adjunctive procedures at the time of MMA (including tonsillectomy, uvulopalatopharyngoplasty, and partial glossectomy) were excluded., Data Extraction: Three coauthors systematically reviewed the articles and updated the review through March 16, 2015. The PRISMA statement was followed. Data were pooled using a random-effects model and analyzed from July 1, 2014, to September 23, 2015., Main Outcomes and Measures: The primary outcomes were changes in the AHI and RDI after MMA for each patient. Secondary outcomes included surgical success, defined as the percentage of patients with more than 50% reduction of the AHI to fewer than 20 events/h, and OSA cure, defined as a post-MMA AHI of fewer than 5 events/h., Results: Forty-five studies with individual data from 518 unique patients/interventions were included. Among patients for whom data were available, 197 of 268 (73.5%) had undergone prior surgery for OSA. Mean (SD) postoperative changes in the AHI and RDI after MMA were -47.8 (25.0) and -44.4 (33.0), respectively; mean (SE) reductions of AHI and RDI outcomes were 80.1% (1.8%) and 64.6% (4.0%), respectively; and 512 of 518 patients (98.8%) showed improvement. Significant improvements were also seen in the mean (SD) postoperative oxygen saturation nadir (70.1% [15.6%] to 87.0% [5.2%]; P < .001) and Epworth Sleepiness Scale score (13.5 [5.2] to 3.2 [3.2]; P < .001). Rates of surgical success and cure were 389 (85.5%) and 175 (38.5%), respectively, among 455 patients with AHI data and 44 (64.7%) and 13 (19.1%), respectively, among 68 patients with RDI data. Preoperative AHI of fewer than 60 events/h was the factor most strongly associated with the highest incidence of surgical cure. Nevertheless, patients with a preoperative AHI of more than 60 events/h experienced large and substantial net improvements despite modest surgical cure rates., Conclusions and Relevance: Maxillomandibular advancement is an effective treatment for OSA. Most patients with high residual AHI and RDI after other unsuccessful surgical procedures for OSA are likely to benefit from MMA.
- Published
- 2016
- Full Text
- View/download PDF
42. Nasal Septal Deviations: A Systematic Review of Classification Systems.
- Author
-
Teixeira J, Certal V, Chang ET, and Camacho M
- Abstract
Objective. To systematically review the international literature for internal nasal septal deviation classification systems and summarize them for clinical and research purposes. Data Sources. Four databases (including PubMed/MEDLINE) were systematically searched through December 16, 2015. Methods. Systematic review, adhering to PRISMA. Results. After removal of duplicates, this study screened 952 articles for relevance. A final comprehensive review of 50 articles identified that 15 of these articles met the eligibility criteria. The classification systems defined in these articles included C-shaped, S-shaped, reverse C-shaped, and reverse S-shaped descriptions of the septal deviation in both the cephalocaudal and anteroposterior dimensions. Additional studies reported use of computed tomography and categorized deviation based on predefined locations. Three studies graded the severity of septal deviations based on the amount of deflection. The systems defined in the literature also included an evaluation of nasal septal spurs and perforations. Conclusion. This systematic review ascertained that the majority of the currently published classification systems for internal nasal septal deviations can be summarized by C-shaped or reverse C-shaped, as well as S-shaped or reverse S-shaped deviations in the anteroposterior and cephalocaudal dimensions. For imaging studies, predefined points have been defined along the septum. Common terminology can facilitate future research.
- Published
- 2016
- Full Text
- View/download PDF
43. Model for prediction of pediatric OSA: Proposal for a clinical decision rule.
- Author
-
Certal V, Silva H, Carvalho C, Costa-Pereira A, Azevedo I, Winck J, Capasso R, and Camacho M
- Subjects
- Child, Child, Preschool, Cohort Studies, Female, Humans, Logistic Models, Male, Pediatrics, Prospective Studies, ROC Curve, Sensitivity and Specificity, Surveys and Questionnaires, Clinical Decision-Making methods, Sleep Apnea, Obstructive diagnosis
- Abstract
Objectives/hypothesis: Obstructive sleep apnea (OSA) is a syndrome frequently diagnosed in children; however, it lacks optimal diagnostic methods. This study aimed to provide a clinical decision rule for predicting pediatric OSA using commonly available clinical information., Study Design: A prospective cohort study., Methods: Children between the ages of 3 to 6 years-old, referred for an otorhinolaryngology consultation due to clinical suspicion of OSA, were recruited from January to June 2014. At baseline age, weight, height, gender, body mass index, Pediatric Sleep Questionnaire (PSQ) scores, tonsil size, and oxygen desaturation index (ODI) were assessed. A logistic regression modeling was used with backward stepwise elimination to develop a prediction model., Results: Sixty-seven children were included with a mean age of 4.51 years. Of the 67 children included in this study, 25 (37.3%) subjects were diagnosed with pediatric OSA. Significant predictors of pediatric OSA in the final model (odds ratio, 95% confidence interval) included PSQ score (5.12; 3.3-6.5), ODI (1.34; 1.0-1.79) and tonsil size (6.7; 3.22-9.75). The final decision rule had a sensitivity of 88% and a specificity of 86%. The area under the receiver operating characteristic curve was 0.897., Conclusion: The proposed clinical decision rule, based on three readily available variables, is a promising discriminating instrument for prediction of OSA among children between 3 and 6 years., Level of Evidence: 2b., (© 2015 The American Laryngological, Rhinological and Otological Society, Inc.)
- Published
- 2015
- Full Text
- View/download PDF
44. Large maxillomandibular advancements for obstructive sleep apnea: An operative technique evolved over 30 years.
- Author
-
Camacho M, Liu SY, Certal V, Capasso R, Powell NB, and Riley RW
- Subjects
- Female, Humans, Male, Time Factors, Treatment Outcome, Mandible surgery, Mandibular Advancement methods, Maxilla surgery, Sleep Apnea, Obstructive surgery
- Abstract
Objective: Obstructive sleep apnea (OSA) can be a challenging disorder to treat. Maxillomandibular advancements (MMAs) generally have high success rates; however, larger advancements have higher success and cure rates. Our aim is to present and to describe the current technique used by the senior authors, which has been successful for performing large advancements, thereby improving post-operative outcomes., Methods: The senior authors have developed and modified their maxillomandibular advancement operative techniques significantly over the past 30 years. The current version of the Riley-Powell MMA technique is described in a step-by-step fashion in this article., Results: Initially, as part of the MMAs, patients underwent maxillomandibular fixation with wires, lag screws and harvested split calvarial bone grafts. The current technique utilizes plates, screws, Erich Arch Bars, and suspension wires which are left in place for 5-6 weeks. Guiding elastics are worn for the first week. The MMA technique described in this article has yielded a success rate over 90% for patients with a body mass index (BMI) <40 kg/m(2) and 81% for patients with a BMI ≥40 kg/m(2)., Conclusion: Large advancements during maxillomandibular advancement surgeries can help improve post-operative obstructive sleep apnea outcomes., (Published by Elsevier Ltd.)
- Published
- 2015
- Full Text
- View/download PDF
45. Myofunctional Therapy to Treat Obstructive Sleep Apnea: A Systematic Review and Meta-analysis.
- Author
-
Camacho M, Certal V, Abdullatif J, Zaghi S, Ruoff CM, Capasso R, and Kushida CA
- Subjects
- Adenoidectomy, Adult, Child, Humans, Oxygen metabolism, Palatal Expansion Technique, Polysomnography, Sleep Apnea, Obstructive diagnosis, Sleep Apnea, Obstructive metabolism, Sleep Apnea, Obstructive physiopathology, Sleep Stages physiology, Snoring physiopathology, Tonsillectomy, Myofunctional Therapy, Sleep Apnea, Obstructive therapy
- Abstract
Objective: To systematically review the literature for articles evaluating myofunctional therapy (MT) as treatment for obstructive sleep apnea (OSA) in children and adults and to perform a meta-analysis on the polysomnographic, snoring, and sleepiness data., Data Sources: Web of Science, Scopus, MEDLINE, and The Cochrane Library., Review Methods: The searches were performed through June 18, 2014. The Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement was followed., Results: Nine adult studies (120 patients) reported polysomnography, snoring, and/or sleepiness outcomes. The pre- and post-MT apneahypopnea indices (AHI) decreased from a mean ± standard deviation (M ± SD) of 24.5 ± 14.3/h to 12.3 ± 11.8/h, mean difference (MD) -14.26 [95% confidence interval (CI) -20.98, -7.54], P < 0.0001. Lowest oxygen saturations improved from 83.9 ± 6.0% to 86.6 ± 7.3%, MD 4.19 (95% CI 1.85, 6.54), P = 0.0005. Polysomnography snoring decreased from 14.05 ± 4.89% to 3.87 ± 4.12% of total sleep time, P < 0.001, and snoring decreased in all three studies reporting subjective outcomes. Epworth Sleepiness Scale decreased from 14.8 ± 3.5 to 8.2 ± 4.1. Two pediatric studies (25 patients) reported outcomes. In the first study of 14 children, the AHI decreased from 4.87 ± 3.0/h to 1.84 ± 3.2/h, P = 0.004. The second study evaluated children who were cured of OSA after adenotonsillectomy and palatal expansion, and found that 11 patients who continued MT remained cured (AHI 0.5 ± 0.4/h), whereas 13 controls had recurrent OSA (AHI 5.3 ± 1.5/h) after 4 y., Conclusion: Current literature demonstrates that myofunctional therapy decreases apnea-hypopnea index by approximately 50% in adults and 62% in children. Lowest oxygen saturations, snoring, and sleepiness outcomes improve in adults. Myofunctional therapy could serve as an adjunct to other obstructive sleep apnea treatments., (© 2015 Associated Professional Sleep Societies, LLC.)
- Published
- 2015
- Full Text
- View/download PDF
46. Maxillomandibular advancement and tracheostomy for morbidly obese obstructive sleep apnea: a systematic review and meta-analysis.
- Author
-
Camacho M, Teixeira J, Abdullatif J, Acevedo JL, Certal V, Capasso R, and Powell NB
- Subjects
- Adult, Comorbidity, Humans, Mandibular Advancement methods, Obesity, Morbid epidemiology, Osteotomy methods, Polysomnography, Sleep Apnea, Obstructive epidemiology, Tracheostomy, Maxilla surgery, Sleep Apnea, Obstructive surgery
- Abstract
Objective: The objective of this study is to systematically review polysomnography data and sleepiness in morbidly obese (body mass index [BMI] ≥40 kg/m(2)) patients with obstructive sleep apnea (OSA) treated with either a maxillomandibular advancement (MMA) or a tracheostomy and to evaluate the outcomes., Data Sources: MEDLINE, Scopus, Web of Science, and the Cochrane Library., Review Methods: A search was performed from inception through April 8, 2014, in each database., Results: Six maxillomandibular advancement studies (34 patients, age 42.42 ± 9.13 years, mean BMI 44.88 ± 4.28 kg/m(2)) and 6 tracheostomy studies (14 patients, age 52.21 ± 10.40 years, mean BMI 47.93 ± 7.55 kg/m(2)) reported individual patient data. The pre- and post-MMA means ± SDs for apnea-hypopnea indices were 86.18 ± 33.25/h and 9.16 ± 7.89/h (P < .00001), and lowest oxygen saturations were 66.58% ± 16.41% and 87.03% ± 5.90% (P < .00001), respectively. Sleepiness following MMA decreased in all 5 patients for whom it was reported. The pre- and posttracheostomy mean ± SD values for apnea indices were 64.43 ± 41.35/h and 1.73 ± 2.68/h (P = .0086), oxygen desaturation indices were 69.20 ± 26.10/h and 41.38 ± 36.28/h (P = .22), and lowest oxygen saturations were 55.17% ± 16.46% and 79.83% ± 4.36% (P = .011), respectively. Two studies reported outcomes for Epworth Sleepiness Scale for 5 patients, with mean ± SD values of 18.80 ± 4.02 before tracheostomy and 2.80 ± 2.77 after tracheostomy (P = .0034)., Conclusion: Data for MMA and tracheostomy as treatment for morbidly obese, adult OSA patients are significantly limited. We caution surgeons about drawing definitive conclusions from these limited studies; higher level studies are needed., (© American Academy of Otolaryngology—Head and Neck Surgery Foundation 2015.)
- Published
- 2015
- Full Text
- View/download PDF
47. The effect of nasal surgery on continuous positive airway pressure device use and therapeutic treatment pressures: a systematic review and meta-analysis.
- Author
-
Camacho M, Riaz M, Capasso R, Ruoff CM, Guilleminault C, Kushida CA, and Certal V
- Subjects
- Humans, Postoperative Period, Preoperative Period, Sleep Apnea, Obstructive physiopathology, Treatment Outcome, Continuous Positive Airway Pressure methods, Continuous Positive Airway Pressure statistics & numerical data, Nasal Surgical Procedures classification, Pressure, Sleep Apnea, Obstructive surgery, Sleep Apnea, Obstructive therapy
- Abstract
Background: The relationship between nasal surgery and its effect on continuous positive airway pressure (CPAP) device therapeutic treatment pressures and CPAP device use has not been previously systematically examined., Study Objectives: To conduct a systematic review and meta-analysis evaluating the effect of isolated nasal surgery on therapeutic CPAP device pressures and use in adults with obstructive sleep apnea (OSA)., Methods: MEDLINE, Scopus, Web of Science, and The Cochrane Library were searched through July 15, 2014. The MOOSE consensus statement and PRISMA statement were followed., Results: Eighteen studies (279 patients) reported CPAP data after isolated nasal surgery. Seven studies (82 patients) reported preoperative and postoperative mean therapeutic CPAP device pressures and standard deviations (SD), which reduced from 11.6 ± 2.2 to 9.5 ± 2.0 centimeters of water pressure (cwp) after nasal surgery. Pooled random effects analysis demonstrated a statistically significant pressure reduction, with a mean difference (MD) of -2.66 cwp (95% confidence interval (CI), -3.65 to -1.67); P < 0.00001. Eleven studies (153 patients) reported subjective, self-reported data for CPAP use; and a subgroup analysis demonstrated that 89.1% (57 of 64 patients) who were not using CPAP prior to nasal surgery subsequently accepted, adhered to, or tolerated it after nasal surgery. Objective, device meter-based hours of use increased in 33 patients from 3.0 ± 3.1 to 5.5 ± 2.0 h in the short term (<6 mo of follow-up)., Conclusion: Isolated nasal surgery in patients with OSA and nasal obstruction reduces therapeutic CPAP device pressures and the currently published literature's objective and subjective data consistently suggest that it also increases CPAP use in select patients., (© 2015 Associated Professional Sleep Societies, LLC.)
- Published
- 2015
- Full Text
- View/download PDF
48. In reference to redefining successful therapy in obstructive sleep apnea: a call to arms.
- Author
-
Certal V, Camacho M, and Capasso R
- Subjects
- Female, Humans, Male, Outcome Assessment, Health Care, Sleep Apnea, Obstructive therapy
- Published
- 2015
- Full Text
- View/download PDF
49. Inferior turbinate classification system, grades 1 to 4: development and validation study.
- Author
-
Camacho M, Zaghi S, Certal V, Abdullatif J, Means C, Acevedo J, Liu S, Brietzke SE, Kushida CA, and Capasso R
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Endoscopy, Female, Humans, Male, Middle Aged, Prospective Studies, Reproducibility of Results, Turbinates pathology
- Abstract
Objectives/hypothesis: To develop a validated inferior turbinate grading scale., Study Design: Development and validation study., Methods: Phase 1 development (alpha test) consisted of a proposal of 10 different inferior turbinate grading scales (>1,000 clinic patients). Phase 2 validation (beta test) utilized 10 providers grading 27 standardized endoscopic photos of inferior turbinates using two different classification systems. Phase 3 validation (pilot study) consisted of 100 live consecutive clinic patients (n = 200 inferior turbinates) who were each prospectively graded by 18 different combinations of two independent raters, and grading was repeated by each of the same two raters, two separate times for each patient., Results: In the development phase, 25% (grades 1-4) and 33% (grades 1-4) were the most useful systems. In the validation phase, the 25% classification system was found to be the best balance between potential clinical utility and ability to grade; the photo grading demonstrated a Cohen's kappa (κ) = 0.4671 ± 0.0082 (moderate inter-rater agreement). Live-patient grading with the 25% classification system demonstrated an overall inter-rater reliability of 71.5% (95% confidence interval [CI]: 64.8-77.3), with overall substantial agreement (κ = 0.704 ± 0.028). Intrarater reliability was 91.5% (95% CI: 88.7-94.3). Distribution for the 200 inferior turbinates was as follows: 25% quartile = grade 1, 50% quartile (median) = grade 2, 75% quartile = grade 3, and 90% quartile = grade 4. Mean turbinate size was 2.22 (95% CI: 2.07-2.34; standard deviation 1.02). Categorical κ was as follows: grade 1, 0.8541 ± 0.0289; grade 2, 0.7310 ± 0.0289; grade 3, 0.6997 ± 0.0289, and grade 4, 0.7760 ± 0.0289., Conclusions: The 25% (grades 1-4) inferior turbinate classification system is a validated grading scale with high intrarater and inter-rater reliability. This system can facilitate future research by tracking the effect of interventions on inferior turbinates., Level of Evidence: 2c., (© 2014 The American Laryngological, Rhinological and Otological Society, Inc.)
- Published
- 2015
- Full Text
- View/download PDF
50. Translation and cross-cultural adaptation of the Pediatric Sleep Questionnaire into Portuguese language.
- Author
-
Certal V, de Lima FF, Winck JC, Azevedo I, and Costa-Pereira A
- Subjects
- Child, Child, Preschool, Culture, Female, Humans, Male, Portugal, Reproducibility of Results, Translating, Sleep Apnea Syndromes diagnosis, Surveys and Questionnaires
- Abstract
Objective: The need for culturally appropriate and linguistically accessible instruments for assessing sleep quality among children has expanded. The Pediatric Sleep Questionnaire (PSQ) is a validated tool for sleep disordered breathing among children. Our aim was to cross-culturally translate and adapt the PSQ into Portuguese language for use in clinical and research settings., Methods: The PSQ was translated into Portuguese language in accordance with the stages recommended by International Guidelines and reviewed by a panel of experts. The caregivers of 180 children (aged from 4 to 12 years) answered the Portuguese version of PSQ. The reliability of the translated questionnaire was measured by Cronbach α, Pearson correlation and Kappa statistics., Results: Reliability analysis yielded an overall Cronbach α of 0.781, confirming the survey's consistency. The Cronbach α of the Portuguese PSQ domains ranged between 0.61 and 0.7. Test-retest reliability for all items was robust with correctness of >90.0% in all items, and the Kappa statistic ranged between 0.5 and 0.8., Conclusion: The Portuguese version of PSQ has sufficient reliability and validity to measure sleep disordered breathing outcomes, and showed to be linguistically accurate and acceptable for use by children in Portugal., (Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.